Apoptosis: Molecular mechanisms, regulation and role in pathogenesis

Canadian Journal of Infectious Diseases

Volumn 8, Issue 2, 1997, Pages 103-109

  Hung, Ryan Wei Yan ^a   Chow, Anthony W ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Apoptosis; Cell death; Pathogenesis; Regulation

Indexed keywords

APOPTOSIS; CELL CYCLE; CELL DEATH; MEDICAL INFORMATION; PATHOGENESIS; REVIEW;

EID: 0030997871     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/131305     Document Type: Review

References (35)

1. Gregory CD. Apoptosis and the Immune Response. New York: Wiley-Liss, 1995.
2. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
3. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-305.
4. Savill J. The innate immune system: Recognition of apoptotic cells. In: Gregory CD, ed. Apoptosis and the Immune Response. New York: Wiley-Liss, 1995:341.
5. Martin SJ, Green GR, Cotter TG. Dicing with death: dissecting the components of apoptosis machinery. Trends Biol Sciences 1994;19:26-30.
6. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;142:67.
7. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 1992;286:331-4.
8. Tomei LD, Shapiro JP, Cope FO. Apoptosis in C3H/10T1/2 mouse embryonic cells: Evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci USA 1993;90:853-7.
9. Zakeri ZF, Quaglino D, Latham T, Lockshin RA. Delayed internucleosomal DNA fragmentation in programmed cell death. FASEB J 1993;7:470-8.
10. Schwartzman RA. Cidlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine Reviews 1993;14:133-51.
11. Yuan J. Molecular control of life and death. Curr Opin Cell Biol 1995;7:211-4.
12. Cohen PL, Eisenberg RA. Fas/APO-1: A cell surface receptor that signals apoptosis. In: Gregory CD, ed. Apoptosis and the Immune Response. New York: Wiley-Liss, 1995:169.
13. Collins MKL, Lopez-Rivas A. The control of apoptosis in mammalian cells. Trends in Biochemical Sciences 1993;18:307-9.
14. Chinnaiyan AM, O'Rouke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death doamin of Fas and initiates apoptosis. Cell 1995;81:505-12.
15. Hsu HL, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NFκB activation. Cell 1995;81:495-504.
16. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/Ced-3 protease necessary for mammalian apoptosis. Nature 1995;76:37-43.
17. Martin SJ, Green GR, Cotter TG. Dicing with death: dissecting the components of apoptosis machinery. Trends Biol Sci 1994;19:26-30.
18. Schwartzman RA, Cidlowski JA. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 1993;14:133-51.
19. Evans CA, Owen-Lynch JP, Whetton AD, Dive C. Activation of the Abelson tyrosine kinase-activity is associated with suppression of apoptosis in hemopoetic cells. Cancer Res 1993;53:1735-8.
20. Wang HG, Miyashita T, Takayama S, et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 1994;9:2751-6.
21. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;89:7491-5.
22. Furuya Y, Berges R, Lundmo P, Isaacs, JT. Cell proliferation, p53 gene expression, and intracellular calcium in programmed death Prostate Model. In: Tomei LD, Cope FO, eds. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994:231.
23. Bissonnette RP, Shi Y, Mahboubi A, Glynn JM, Green DR. c-myc and Apoptosis. In: Tomei LD, Cope FO, eds. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994:327.
24. Smith CA, Grimes EA, McCarthy NJ, Williams GT. Multiple gene regulation of apoptosis: Significance in immunology and oncology. In: Tomei LD, Cope FO, eds. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994:43.
25. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the Bcl-2 gene. Cancer Res 1994;54:3131-5.
26. Miyashita T, Reed JC. Tumor-suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 1995;80:293-9.
27. Budtz PE. Epidermal homeostasis: A new model that includes apoptosis. In: Tomei LD, Cope FO, eds. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994:165.
28. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
29. Smith CA, Grimes EA, McCarthy NJ, Williams GT. Multiple gene regulation of apoptosis: significance in immunology and oncology. In: Tomei LD, Cope FO, eds. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994:43.
30. White E, Gooding LR. Regulation of apoptosis by human adenoviruses. In: Tomei LD, Cope FO, eds. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994:111.
31. Gougeon ML, Montagnier L. Apoptosis in peripheral T lymphocytes during HIV infection: Influence of superantigens and correlation with AIDS pathogenesis. in: Tomei LD, Cope FO, eds. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994:5.
32. Watanabe-Ohnishi R, Low DE, McGeer A, et al. Selective depletion of Vβ-bearing T cells in patients with severe invasive Group A streptococcal infections and Streptococcal Toxic Shock Syndrome. J Infect Dis 1995;171:74-84.
33. Miethke T, Wahl C, Heeg K, Wagner H. Superantigens: The paradox of T-cell activation versus inactivation. Int Arch Allergy Immunol 1995;106:3-7.
34. Posnett DN, Kabak S, Asch A, Hodtsev AS. HIV-1 replication in T cells dependent on TCR Vβ expression. In: Huber BT, Palmer E, eds, Superantigens: A Pathogen's View of the Immune System. Plainview: Cold Spring Harbor Laboratory Press, 1993:139.
35. Posnett DN. CMV drives HIV replication in selected Vb subsets: Evidence for a herpes virus superantigen. National Symposium of Basic Aspects of Immunology. Bethesda, MD, May 1-3, 1996. (Abst)